You have 9 free searches left this month | for more free features.

City

Guangzhou (1)

Shanghai (1)

Condition

Psoriasis (2)

Ulcerative Colitis (UC) (1)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Sign in for free

Phase

phase 3 (2)

phase 2 (1)

Sponsor

Innovent Biologics (Suzhou) Co. Ltd. (3)

Collaborator

Intervention

ibi112 (3)

ibi112/placebo (1)

placebo (1)

placebo /ibi112 (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

ibi112

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Psoriasis Trial (IBI112, IBI112/)

Not yet recruiting

Psoriasis

IBI112
IBI112/placebo

(no location specified)

Sep 19, 2023

Psoriasis Trial in Shanghai (IBI112, /IBI112)

Not yet recruiting

Psoriasis

IBI112
placebo /IBI112

Shanghai, Shanghai, China

Shanghai Skin Disease Hospital

Dec 1, 2022

Ulcerative Colitis (UC) Trial in Guangzhou (Placebo, IBI112)

Recruiting

Ulcerative Colitis (UC)

Placebo
IBI112

Guangzhou, Guangdong, China

First Affiliated Hospital of Sun Yat-sen University

Sep 20, 2022